Gerry Connolly said...
You should foresee that just continuing as we continue to maximize the EpiPen franchise.
Context
Connolly questions profit motives behind EpiPen pricing during an investor meeting.
09/20/2016
Connolly questions profit motives behind EpiPen pricing during an investor meeting.
09/20/2016